Dermatologic Manifestations of Patients With Severe and Non-Severe COVID-19 Infection: A Cross-Sectional Study

    August 2024 in “ Journal of Research in Clinical Medicine ”
    Mehrad Amirnia, Mehdi Haghdoost, Khazar Raeisnia … Mehdi Amirnia
    Studysummary In this study, researchers observed that patients with COVID-19 can develop a variety of skin lesions, with maculopapular rash, telogen effluvium, and urticaria showing significant associations with both the timing of symptom onset and the severity of the disease.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jrcm.tbzmed.ac.ir →
    Discuss this study in the Community →

    Research cited in this study 9

    1. Acute Telogen Effluvium: A Sequela of COVID-19 Infection GLOBAL JOURNAL FOR RESEARCH ANALYSIS · 2022
    2. Rash Morphology as a Predictor of COVID-19 Severity: A Systematic Review of the Cutaneous Manifestations of COVID-19 Skin health and disease · 2022
    3. Prevalence of Telogen Effluvium Hair Loss in COVID-19 Patients and Its Relationship with Disease Severity Journal of medicine and life · 2022
    4. Skin Manifestations Associated with COVID-19 Anais Brasileiros de Dermatologia · 2021
    5. COVID-19 Induced Telogen Effluvium Dermatologic Therapy · 2021
    6. A Systematic Review of Dermatologic Manifestations Among Adult Patients With COVID-19 Diagnosis Skin health and disease · 2021
    7. Telogen Effluvium Associated with COVID-19 Infection Dermatologic Therapy · 2021
    8. Telogen Effluvium: A Sequela of COVID-19 International Journal of Dermatology · 2020
    9. Telogen Effluvium: Causes, Diagnosis, and Treatment InTech eBooks · 2017